Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 25:2019:6827215.
doi: 10.1155/2019/6827215. eCollection 2019.

Anterior Segment Biometry with Phenylephrine and Tropicamide during Accommodation Imaged with Ultralong Scan Depth Optical Coherence Tomography

Affiliations

Anterior Segment Biometry with Phenylephrine and Tropicamide during Accommodation Imaged with Ultralong Scan Depth Optical Coherence Tomography

Junna Zhang et al. J Ophthalmol. .

Abstract

Purpose: To investigate the influence of phenylephrine and tropicamide on anterior segment biometry with ultralong scan depth optical coherence tomography (UL-OCT) during accommodation.

Methods: In this study, 20 left eyes of healthy volunteers with a mean ± standard deviation age of 31.05 ± 5.84 years and a mean refraction of -1.16 ± 1.11 diopters (range 0∼-3.0 D) were imaged using UL-OCT after instillation of artificial tears, phenylephrine, and tropicamide in three follow-up trials, respectively. At each follow-up trial, two repeated measurements were performed at states of relax and 5D accommodative stimulation. The dimensional parameters included central corneal thickness (CCT), anterior chamber depth (ACD), pupil diameter (PD), lens thickness (LT), and horizontal radii of the lens anterior and posterior surface curvatures (LAC and LPC).

Results: Tropicamide led to larger pupil, deeper ACD, thinner LT, and flatter crystalline lens surface (P < 0.05). Phenylephrine induced an increase in PD (P < 0.05), while no significant changes were seen in ACD, LT, LAC, and LPC (P > 0.05). CCT did not change after both phenylephrine and tropicamide instillation in this study (P > 0.05). Tropicamide induced the loss of accommodation and phenylephrine achieved pupil dilation without affecting the accommodation. PD, ACD decreased, LT increased significantly and the anterior and posterior surface of the lens in a 6.294 mm of diameter optical zone became steeper during accommodation after administration of phenylephrine (P < 0.05).

Conclusion: The anterior segment physiology changed after tropicamide instillation. Besides, tropicamide induced the loss of accommodation and phenylephrine preserved the accommodation with a larger pupil. And, the anterior and posterior surface of lens in a 6.294 mm of diameter optical zone became steeper during the accommodation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Corrected OCT images at the relax (left) and accommodative states (5.0 D, right) in a 26-year-old female with −1.25 D myopia with (a) artificial tears, (b) phenylephrine, and (c) tropicamide. These three images were corrected only at both corneal surfaces.

References

    1. Lee Y. I., Kim J. S., Nam K. R. The pupillary dilatation effect of phenylephrine 2.5% versus 10% in patients with diabetes. Journal of the Korean Ophthalmological Society. 1997;38(9):1655–1659.
    1. Loewenfeld I. E., Newsome D. A. Iris mechanics I. Influence of pupil size on dynamics of pupillary movements. American Journal of Ophthalmology. 1971;71(1):347–362. doi: 10.1016/0002-9394(71)90410-7. - DOI - PubMed
    1. Cheng H.-C., Hsieh Y.-T. Short-term refractive change and ocular parameter changes after cycloplegia. Optometry and Vision Science. 2014;91(9):1113–1117. doi: 10.1097/opx.0000000000000339. - DOI - PubMed
    1. Chang S. W., Lo A. Y., Su P. F. Anterior segment biometry changes with cycloplegia in myopic adults. Optometry & Vision Science. 2016;93(1):12–18. doi: 10.1097/opx.0000000000000748. - DOI - PubMed
    1. Palamar M., Alkan Z., Egrilmez S., Yagci A. Influences of tropicamide on anterior segment parameters with pentacam in healthy individuals. Journal of Ocular Pharmacology and Therapeutics. 2013;29(3):349–352. doi: 10.1089/jop.2012.0145. - DOI - PubMed

LinkOut - more resources